← Back to Search

Dermal Filler

Allergan Vollure for Atrophic Scar (JVAS Trial)

N/A
Waitlist Available
Research Sponsored by Siperstein Dermatology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 90 days after last injection
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing Juvéderm Vollure, a new injectable filler, to see if it is safe and effective. Subjects will get Juvéderm Vollure on one side of their face and Saline on the other side. They will come back 30 days later and possibly get the Juvéderm Vollure again. They will fill out questionnaires and be assessed for short-term and long-term adverse events.

Eligible Conditions
  • Atrophic Scar

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 90 days after last injection
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 90 days after last injection for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Quantitiative Global Scaring Grading System (QGSGS) score
Secondary study objectives
24 Month Global Aesthetic Improvement Scale (GAIS) Results
24 Month Quantitiative Global Scaring Grading System (QGSGS) Results
Adverse Events
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Treatment With Juvederm Vollure RightExperimental Treatment1 Intervention
Injection of Juvederm Vollure on one half of the face, placebo on the other side
Group II: Treatment Juvederm Vollure LeftExperimental Treatment1 Intervention
Injection of Juvederm Vollure on one half of the face, placebo on the other side

Find a Location

Who is running the clinical trial?

Siperstein DermatologyLead Sponsor
3 Previous Clinical Trials
49 Total Patients Enrolled
AllerganIndustry Sponsor
781 Previous Clinical Trials
276,639 Total Patients Enrolled
~3 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top